Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

Group 1: Company Performance - McKesson (MCK) has gained approximately 27.9% year-to-date, outperforming the average loss of 4.9% in the Medical group [4] - The Zacks Consensus Estimate for McKesson's full-year earnings has increased by 1.5% over the past quarter, indicating improving analyst sentiment [3] - McKesson belongs to the Medical - Dental Supplies industry, which has seen a loss of about 0.9% this year, further highlighting MCK's strong performance within its specific industry [5] Group 2: Industry Context - The Medical group is currently ranked 6 within the Zacks Sector Rank, which evaluates the strength of 16 individual sector groups [2] - The Medical - Biomedical and Genetics industry, where Benitec Biopharma Limited (BNTC) operates, is ranked 87 and has experienced a decline of 4.8% since the beginning of the year [6] - Investors should monitor both McKesson and Benitec Biopharma Limited as they have shown solid performance relative to their respective sectors [6]